Aptorum Group Limited and DiamiR Biosciences Corp. have agreed to extend the termination date for their merger agreement, management services agreement, and intellectual property license agreement to July 31, 2026. This extension is intended to satisfy closing conditions for the merger. Aptorum Group Limited is a biotechnology company focused on therapeutic development.
